BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8998143)

  • 1. Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA.
    Hirano T; Otake H; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1997 Jan; 38(1):20-6. PubMed ID: 8998143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
    Hirano T; Otake H; Kazama K; Wakabayashi K; Zama A; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA.
    Hirano T; Otake H; Yoshida I; Endo K
    J Nucl Med; 1995 Feb; 36(2):202-7. PubMed ID: 7830114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.
    Kobayashi H; Sakahara H; Hosono M; Shirato M; Endo K; Kotoura Y; Yamamuro T; Konishi J
    Radiology; 1994 Jan; 190(1):277-80. PubMed ID: 8259419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-d,1-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors.
    Suess E; Malessa S; Ungersböck K; Kitz P; Podreka I; Heimberger K; Hornykiewicz O; Deecke L
    J Nucl Med; 1991 Sep; 32(9):1675-81. PubMed ID: 1880567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?
    Amin A; Mustafa M; Abd El-Hadi E; Monier A; Badwey A; Saad E
    J Neurooncol; 2015 Jan; 121(2):303-9. PubMed ID: 25349131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
    Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
    Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
    Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
    Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
    Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.
    Amin A; Moustafa H; Ahmed E; El-Toukhy M
    J Neurooncol; 2012 Feb; 106(3):579-87. PubMed ID: 21912937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does (99m)Tc-Sestamibi in high-grade malignant brain tumors reflect blood-brain barrier damage only?
    Staudenherz A; Fazeny B; Marosi C; Nasel C; Hoffmann M; Puig S; Killer M; Leitha T
    Neuroimage; 2000 Jul; 12(1):109-11. PubMed ID: 10875907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
    Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
    Lastoria S; Colao A; Vergara E; Ferone D; Varrella P; Merola B; Lombardi G; Salvatore M
    Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99m (V) DMSA scintigraphy: a prospective study.
    Shinya T; Sato S; Kunisada T; Inai R; Yanai H; Ozaki T; Kanazawa S
    Nucl Med Commun; 2015 Aug; 36(8):802-7. PubMed ID: 25932541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult].
    Lamy-Lhullier C; Dubois F; Blond S; Lecouffe P; Steinling M
    Neurochirurgie; 1999 May; 45(2):110-7. PubMed ID: 10448650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
    Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
    Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of pentavalent technetium-99m dimercaptosuccinic acid in idiopathic synovial chondromatosis.
    Kobayashi H; Kotoura Y; Hosono M; Tsuboyama T; Nishijima N; Sakahara H; Konishi J
    Ann Nucl Med; 1995 Aug; 9(3):153-5. PubMed ID: 8534590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.